News | Point of Care Testing | July 26, 2017

Siemens Healthineers to Acquire Epocal from Alere

Acquisition will bring handheld epoc Blood Analysis System into Siemens’ blood gas diagnostics line

Siemens Healthineers to Acquire Epocal from Alere

July 26, 2017 — Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal Inc. develops and provides point-of-care blood diagnostic systems for healthcare enterprises, including the epoc Blood Analysis System, a handheld, wireless testing solution. Financial details of the transaction are not being disclosed. The transaction is subject to the completion of Abbott’s acquisition of Alere, as well as antitrust approvals and other customary closing conditions.

Healthcare systems continue to look for ways to elevate patient experience and satisfaction as well as the quality of care. Health networks may have varying testing needs near to their patients at the point of care in physician’s offices, clinics, emergency departments and labs. With a complete offering for blood gas diagnostics following this acquisition, from a low-volume, single-use handheld device up to a high-volume, multi-use benchtop solution, Siemens Healthineers said it can help customers improve their workflows and utilize the correct system for the needs of their particular settings.

Arterial blood gases are an important routine investigation to monitor the acid-base balance of patients. They play an important role in the work-up and management of critically ill patients and may help in diagnosing pulmonary and metabolic disorders. They indicate the severity of a condition and help to assess treatment. Blood gas test systems are an important component in critical care settings such as hospitals, clinics, emergency departments and pulmonary laboratories.

The epoc Blood Analysis System is a handheld, wireless testing solution that provides blood gas, electrolyte and metabolite results near the patient in approximately 30 seconds after sample introduction. The system is comprised of the epoc room-temperature stable BGEM test card, epoc reader and epoc host2 mobile computer. Each single-use epoc BGEM test card features smartcard technology with a full menu of tests on one card.

For more information: www.usa.healthcare.siemens.com, www.alere-epoc.com


Related Content

News | Point of Care Testing

August 5, 2019 — A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ...

Home August 05, 2019
Home
News | Point of Care Testing | Dave Fornell

July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is once ...

Home July 17, 2017
Home
Feature | Point of Care Testing | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios

Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on ...

Home May 05, 2017
Home
Technology | Point of Care Testing

January 27, 2017 — HyperMed Imaging Inc. announced that it has received clearance from the U.S. Food and Drug ...

Home January 27, 2017
Home
Feature | Point of Care Testing | Ravi Chawat

Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology and ...

Home December 30, 2016
Home
Feature | Point of Care Testing

December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...

Home December 07, 2016
Home
Technology | Point of Care Testing

November 10, 2016 — Siemens Healthineers announced U.S. Food and Drug Administration (FDA) 510(k) clearance for a hand ...

Home November 10, 2016
Home
News | Point of Care Testing

February 3, 2016 — Abbott and Alere Inc. announced a definitive agreement for Abbott to acquire Alere. Under the terms ...

Home February 03, 2016
Home
News | Point of Care Testing

December 22, 2015 — Trinity Biotech plc announced submission of its Meritas Point of Care Analyzer and Meritas cardiac ...

Home December 22, 2015
Home
News | Point of Care Testing

October 13, 2015 — The Lancet published results online that show Abbott’s ARCHITECT STAT High Sensitive Troponin-I ...

Home October 13, 2015
Home
Subscribe Now